| 注册
首页|期刊导航|中国医药科学|恩度联合顺铂治疗晚期非小细胞肺癌临床分析

恩度联合顺铂治疗晚期非小细胞肺癌临床分析

赵培革

中国医药科学Issue(20):47-48,2.
中国医药科学Issue(20):47-48,2.

恩度联合顺铂治疗晚期非小细胞肺癌临床分析

Clinical effect of endostar combined with cisplatin intrapleural injection in the treatment of advanced non-small cell lung cancer

赵培革1

作者信息

  • 1. 山东省聊城市人民医院呼吸内科,山东聊城252000
  • 折叠

摘要

Abstract

Objective To investigate the clinical Effect of Endostar combined with cisplatin intrapleural injection in the treatment of advanced non-small cell lung cancer. Methods 117 cases of patients withadvanced non small cell lung cancer patients In 2010 February-2013 year in February were collected in the hospital,who were randomly divided into chemotherapy group(control group) 58 cases and Endostar combined with cisplatin group(observation group)59 cases,The clinicalefficacy and adverse reactions of two groups of patients observation were observed. Results The observation group the total effective rate was 59.32%,total effective rate of the control group was 37.93%; the two groups,the difference was statistically significant(P<0.05). Adverse reactions of two groups, the difference was not statistically significant(P > 0.05). Conclusion Endostar combined with cisplatin intrapleural injection in the treatment of advanced non-small cell lung cancer clinical efficacy significantly,it is worth in clinical application..

关键词

恩度/顺铂/非小细胞肺癌

Key words

Endostatin/Cisplatin/Non small cell lung cancer

分类

医药卫生

引用本文复制引用

赵培革..恩度联合顺铂治疗晚期非小细胞肺癌临床分析[J].中国医药科学,2013,(20):47-48,2.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文